The Challenge of Change - Managing Excipients Control
Colorcon
22-Jun-2004 - India's Bal Pharma has announced plans to enter the markets of the Commonwealth of Independent States (CIS) and is looking for trade partners and marketing tie-ups in the region for its range of formulations and bulk drugs.
21-Jun-2004 - UK biotechnology company Xenova has been given regulatory approval for a manufacturing facility for clinical trial materials for its own use, as well as for its clients.
21-Jun-2004 - In the UK, the House of Commons Health Committee is to undertake a broad-ranging inquiry into the influence of the pharmaceutical industry on health policy, to look for conflicts between the need for new drugs and commercial interests, reports Phil Taylor.
21-Jun-2004 - Rudolf Hanko, formerly head of the fine chemicals business unit at Bayer, has joined Degussa as head of the company's exclusive synthesis business line, part of Degussa's Exclusive Synthesis & Catalysts business unit.
17-Jun-2004 - Companies developing new drugs for the global market must deal with the rising costs of the R&D process - and outsourcing may well be the best route, according to Dr Faiz Kermani, a specialist in outsourcing and research development.
17-Jun-2004 - A new drug delivery company, Merrion Pharmaceuticals, has been set up to commercialise various technologies originally developed at Ireland's Elan, which sold off many of its assets after growing too quickly throughout the 1990s.
16-Jun-2004 - The European Union parallel trade in pharmaceuticals is offering few benefits to cash-strapped national healthcare systems and may raise the risk of medication errors and entry of counterfeit medicines into the supply chain, according to a new report.
16-Jun-2004 - Ireland's Elan has signed its first major contract manufacturing and supply agreement in a development that reinforces its credentials as a player in the outsourcing sector.
15-Jun-2004 - Swiss active pharmaceutical ingredients (API) company Siegfried believes it has found a shortcut on the path to market for generic drugs in the European Union, allowing it to launch drugs immediately after their patents expire.
15-Jun-2004 - Vectura, a UK biotechnology company which is developing an inhaled alternative to orally acting impotence drugs such as Pfizer's Viagra (sildenafil), has announced plans to float on the London stock market.
14-Jun-2004 - France's Galenix is to set up a US subsidiary as part of a drive to raise the profile of its drug delivery technologies.
14-Jun-2004 - India's Jubilant Organosys has bought two companies in Belgium as part of a drive to improve its presence in the European market for generic drugs and active pharmaceutical ingredients (APIs).
14-Jun-2004 - Membrane separation systems dominate the European market for industrial process water treatment equipment, and the technology looks set to consolidate and spread to Eastern Europe.
10-Jun-2004 - Scottish biotech firm CXR biosciences and Edinburgh's Roslin Institute have entered into a collaboration with Geron to develop a new technique that promises to reduce the need to test drugs on animals.
09-Jun-2004 - US-based healthcare conglomerate Cardinal Health has stepped up its presence in the European market with the appointment of a new management team for the region based in the UK.
09-Jun-2004 - International R&D group SRI has set up a new company to harvest the growing number of new therapeutic agents in development at bioresearch laboratories in Asia.
08-Jun-2004 - Hospira, the hospital products company spun out of Abbott Laboratories earlier this year, has acquired a manufacturing facility that will help it grow its pharmaceutical injectable and outsourcing business.
07-Jun-2004 - Novartis generics subsidiary Sandoz has continued its expansion with the purchase of Canadian generic drugmaker Sabex Holdings for $565 million (€459m) in cash, bringing in a new range of injectable products.
03-Jun-2004 - German contract manufacturer Strathmann Biotec has won a contract to manufacture clinical supplies a new type of cancer treatment in development at Sweden's Active Biotech.
02-Jun-2004 - Cobra Biomanufacturing of the UK saw its losses halve in the first half of the current fiscal year, in the face of continuing declines in the market for contract manufacturing of plasmid DNA.
01-Jun-2004 - Fisher Scientific subsidiary Perbio last week opened a new facility in the UK to manufacture its Hyclone range of cell culture equipment and mediathat ramps up its liquid production capacity by a factor of four, reports Phil Taylor.
27-May-2004 - Danish ingredients company Chr Hansen has ramped up its production capacity in the US for its pharmaceutical products via a $10 million (€8.2m) expansion of its facilities in Stoughton in the US.
27-May-2004 - Novartis subsidiary Lek has opened a new plant in Romania that will supply antibiotic generics and ingredients to markets across Europe.
27-May-2004 - Lanxess, the fine chemicals unit that is due to be spun out of Germany's Bayer next year, will be headed by Axel Westerhaus, currently in charge of the group's polyethers business in the US.
25-May-2004 - Japanese drug companies Yamanouchi and Fujisawa have said that the entity to be created via their merger next year will be called Astellas Pharma, drawing on a Japanese word that means 'shine on tomorrow'.